TABLE 2.
Individual model CMV and EBV effect estimates, confidence intervals, and P values for model predictionsa
| Cell type | Phenotype | Estimate (95% confidence interval) |
||
|---|---|---|---|---|
| CMV | CMV × time | EBV | ||
| CD4 | Activation | 0.15 (0.03, 0.26)* | 0.05 (−0.05, 0.15) | |
| Cycling | 0.10 (−0.06, 0.25) | −0.06 (−0.19, 0.06) | ||
| Degranulation | 0.51 (0.11, 0.90)* | −0.13 (−0.22, −0.04)** | 0.07 (−0.03, 0.18) | |
| PD-1 | 0.25 (−0.07, 0.57) | −0.09 (−0.16, −0.02)* | −0.06 (−0.15, 0.03) | |
| Treg | −0.12 (−0.27, 0.03) | −0.07 (−0.20, 0.06) | ||
| CD8 | Activation | 0.04 (−0.10, 0.18) | 0.09 (−0.02, 0.21) | |
| Cycling | 0.98 (0.46, 1.50)** | −0.18 (−0.30, −0.07)** | −0.01 (−0.12, 0.10) | |
| Degranulation | −0.18 (−0.30, −0.06)** | −0.02 (−0.13, 0.08) | ||
| PD-1 | 0.34 (−0.04, 0.72) | −0.11 (−0.20, −0.03)* | −0.05 (−0.15, 0.05) | |
a
Value for CMV-time interaction (CMV × time) is included if significant. Values for EBV-time interaction were not significant. *, P < 0.05; **, P < 0.01.